394 related articles for article (PubMed ID: 24564736)
21. A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.
Tao S; Wang Z; Feng J; Hsu FC; Jin G; Kim ST; Zhang Z; Gronberg H; Zheng LS; Isaacs WB; Xu J; Sun J
Carcinogenesis; 2012 Mar; 33(3):598-603. PubMed ID: 22219177
[TBL] [Abstract][Full Text] [Related]
22. Endometrial vezatin and its association with endometriosis risk.
Holdsworth-Carson SJ; Fung JN; Luong HT; Sapkota Y; Bowdler LM; Wallace L; Teh WT; Powell JE; Girling JE; Healey M; Montgomery GW; Rogers PA
Hum Reprod; 2016 May; 31(5):999-1013. PubMed ID: 27005890
[TBL] [Abstract][Full Text] [Related]
23. SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies.
Xu Z; Taylor JA
Nucleic Acids Res; 2009 Jul; 37(Web Server issue):W600-5. PubMed ID: 19417063
[TBL] [Abstract][Full Text] [Related]
24. Alzheimer's Disease Risk Polymorphisms Regulate Gene Expression in the ZCWPW1 and the CELF1 Loci.
Karch CM; Ezerskiy LA; Bertelsen S; ; Goate AM
PLoS One; 2016; 11(2):e0148717. PubMed ID: 26919393
[TBL] [Abstract][Full Text] [Related]
25. In-silico analysis of inflammatory bowel disease (IBD) GWAS loci to novel connections.
Mesbah-Uddin M; Elango R; Banaganapalli B; Shaik NA; Al-Abbasi FA
PLoS One; 2015; 10(3):e0119420. PubMed ID: 25786114
[TBL] [Abstract][Full Text] [Related]
26. Identification of breast cancer associated variants that modulate transcription factor binding.
Liu Y; Walavalkar NM; Dozmorov MG; Rich SS; Civelek M; Guertin MJ
PLoS Genet; 2017 Sep; 13(9):e1006761. PubMed ID: 28957321
[TBL] [Abstract][Full Text] [Related]
27. SNP eQTL status and eQTL density in the adjacent region of the SNP are associated with its statistical significance in GWA studies.
Gorlov I; Xiao X; Mayes M; Gorlova O; Amos C
BMC Genet; 2019 Nov; 20(1):85. PubMed ID: 31718536
[TBL] [Abstract][Full Text] [Related]
28. Identification of candidate genes for prostate cancer-risk SNPs utilizing a normal prostate tissue eQTL data set.
Thibodeau SN; French AJ; McDonnell SK; Cheville J; Middha S; Tillmans L; Riska S; Baheti S; Larson MC; Fogarty Z; Zhang Y; Larson N; Nair A; O'Brien D; Wang L; Schaid DJ
Nat Commun; 2015 Nov; 6():8653. PubMed ID: 26611117
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive evaluation of disease- and trait-specific enrichment for eight functional elements among GWAS-identified variants.
Markunas CA; Johnson EO; Hancock DB
Hum Genet; 2017 Jul; 136(7):911-919. PubMed ID: 28567521
[TBL] [Abstract][Full Text] [Related]
30. Mechanistic insights into genetic susceptibility to prostate cancer.
Tian P; Zhong M; Wei GH
Cancer Lett; 2021 Dec; 522():155-163. PubMed ID: 34560228
[TBL] [Abstract][Full Text] [Related]
31. Genetic variants and risk of prostate cancer using pathway analysis of a genome-wide association study.
Kim YS; Kim Y; Choi JW; Oh HE; Lee JH
Neoplasma; 2016; 63(4):629-34. PubMed ID: 27268928
[TBL] [Abstract][Full Text] [Related]
32. Association test based on SNP set: logistic kernel machine based test vs. principal component analysis.
Zhao Y; Chen F; Zhai R; Lin X; Diao N; Christiani DC
PLoS One; 2012; 7(9):e44978. PubMed ID: 23028716
[TBL] [Abstract][Full Text] [Related]
33. A genome-wide survey over the ChIP-on-chip identified androgen receptor-binding genomic regions identifies a novel prostate cancer susceptibility locus at 12q13.13.
Feng J; Sun J; Kim ST; Lu Y; Wang Z; Zhang Z; Gronberg H; Isaacs WB; Zheng SL; Xu J
Cancer Epidemiol Biomarkers Prev; 2011 Nov; 20(11):2396-403. PubMed ID: 21960693
[TBL] [Abstract][Full Text] [Related]
34. GWAS in cancer: progress and challenges.
Liang B; Ding H; Huang L; Luo H; Zhu X
Mol Genet Genomics; 2020 May; 295(3):537-561. PubMed ID: 32048005
[TBL] [Abstract][Full Text] [Related]
35. An expanded variant list and assembly annotation identifies multiple novel coding and noncoding genes for prostate cancer risk using a normal prostate tissue eQTL data set.
DeRycke MS; Larson MC; Nair AA; McDonnell SK; French AJ; Tillmans LS; Riska SM; Baheti S; Fogarty ZC; Larson NB; O'Brien DR; Cheville JC; Wang L; Schaid DJ; Thibodeau SN
PLoS One; 2019; 14(4):e0214588. PubMed ID: 30958860
[TBL] [Abstract][Full Text] [Related]
36. Prostate cancer risk-associated variants reported from genome-wide association studies: meta-analysis and their contribution to genetic Variation.
Kim ST; Cheng Y; Hsu FC; Jin T; Kader AK; Zheng SL; Isaacs WB; Xu J; Sun J
Prostate; 2010 Dec; 70(16):1729-38. PubMed ID: 20564319
[TBL] [Abstract][Full Text] [Related]
37. Integrative analysis of liver-specific non-coding regulatory SNPs associated with the risk of coronary artery disease.
Selvarajan I; Toropainen A; Garske KM; López Rodríguez M; Ko A; Miao Z; Kaminska D; Õunap K; Örd T; Ravindran A; Liu OH; Moreau PR; Jawahar Deen A; Männistö V; Pan C; Levonen AL; Lusis AJ; Heikkinen S; Romanoski CE; Pihlajamäki J; Pajukanta P; Kaikkonen MU
Am J Hum Genet; 2021 Mar; 108(3):411-430. PubMed ID: 33626337
[TBL] [Abstract][Full Text] [Related]
38. Pathway Analysis of Genes Identified through Post-GWAS to Underpin Prostate Cancer Aetiology.
Farashi S; Kryza T; Batra J
Genes (Basel); 2020 May; 11(5):. PubMed ID: 32397189
[TBL] [Abstract][Full Text] [Related]
39. Integrative pathway analysis of genome-wide association studies and gene expression data in prostate cancer.
Jia P; Liu Y; Zhao Z
BMC Syst Biol; 2012; 6 Suppl 3(Suppl 3):S13. PubMed ID: 23281744
[TBL] [Abstract][Full Text] [Related]
40. Top associated SNPs in prostate cancer are significantly enriched in cis-expression quantitative trait loci and at transcription factor binding sites.
Jiang J; Jia P; Shen B; Zhao Z
Oncotarget; 2014 Aug; 5(15):6168-77. PubMed ID: 25026280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
